Nipradilol
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
This is the current revision of this page, as edited by Citation bot (talk | contribs) at 18:05, 31 August 2023 (Add: doi-access. | Use this bot. Report bugs. | Suggested by Headbomb | Linked from Wikipedia:WikiProject_Academic_Journals/Journals_cited_by_Wikipedia/Sandbox3 | #UCB_webform_linked 1275/1975). The present address (URL) is a permanent link to this version.
Revision as of 18:05, 31 August 2023 by Citation bot (talk | contribs) (Add: doi-access. | Use this bot. Report bugs. | Suggested by Headbomb | Linked from Wikipedia:WikiProject_Academic_Journals/Journals_cited_by_Wikipedia/Sandbox3 | #UCB_webform_linked 1275/1975)
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Names | |
---|---|
IUPAC name
[8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl] nitrate
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C15H22N2O6 | |
Molar mass | 326.349 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
Nipradilol is a beta blocker and nitric oxide donor.[1]
References
[edit]- ^ Inoue, K; Kei Noguchi, K; Masumoto, M; Wakakura, G (2011). "Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma". Clinical Ophthalmology. 5: 1211–6. doi:10.2147/OPTH.S23233. PMC 3180485. PMID 21966188.
Forms | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Targets |
| ||||||||||||||
NO donors (prodrugs) |
| ||||||||||||||
Enzyme (inhibitors) |
| ||||||||||||||
Others |
| ||||||||||||||
See also: Receptor/signaling modulators |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |